NFATC1 Antilichaam - middengebied: FITC (ARP38743_P050-FITC)

Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1

NFAT2, NFATc, NF-ATC, NF-ATc1.2

4772

B5B2M8

NP_006153

Human

The immunogen is a synthetic peptide directed towards the middle region of human NFATC1

NFATC1 is a component of the nuclear factor of activated T cells DNA-binding transcription complex. This complex consists of at least two components: a preexisting cytosolic component that translocates to the nucleus upon T cell receptor (TCR) stimulation

YWHAQ; OGT; PML; GZF1; FOXP3; HDAC4; PIAS1; SUMO1; UBE2I; RPS6KB1; RPS6KA3; HDAC2; HDAC1; HNRNPA1; TUBA1A; KPNB1; HDAC5; KAT2B; EP300; PARP1; HDAC3; PPP3R1; MAPK14; GNB2L1; PRKCA; SPI1; PIM1; EGR2; EGR1

FITC: Fluorescein Isothiocyanate

Polyclonal Antibody

WB, IHC

Affinity Purified

0.5 mg/ml

Human: 100%

Liquid. Purified antibody supplied in 1x PBS buffer.

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.

89kDa

Kumar, R., (2006) Mol. Cancer Res. 4 (9), 655-665

Wet Ice

825

NFATC1

NFATC1

Rabbit

Nuclear factor of activated T-cells c1 isoform IA-IXS EMBL ACG55583.1

NM_005093

STLMPAAPGVSPKLHDLSPAAYTKGVASPGHCHLGLPQPAGEAPAVQDVP